Target intelligence / Profile preview

Epiretinal membrane (ERM)

Target
ERM
Molecular classification
Other
01

Overview

Epiretinal membrane (ERM) is a thin, fibrocellular layer of scar tissue that develops on the inner surface of the retina, most often over the central macular region[1][2][4][5][6]. It is usually associated with aging and posterior vitreous detachment, but may also occur after retinal surgery, inflammation, vascular disease, or trauma[3][4][5][6]. ERMs can cause painless vision distortion and blurring, where straight lines appear wavy (metamorphopsia) and central vision may be impaired[3][5][7]. Most cases are mild and do not require intervention; if vision is significantly impaired, the membrane can be removed surgically (vitrectomy and membrane peel). There are no effective drug treatments for ERM[1][2][3][4][5][6].

Other names
Macular puckercellophane maculopathyepi-macular membranepre-macular fibrosissurface-wrinkling retinopathypreretinal macular fibrosispre-retinal membrane
02

Mechanism of action

Not applicable; surgical removal (vitrectomy and membrane peel) is the standard therapy, not molecular drugs

03

Biological functions

Other (this is a pathological tissue formation, not a single biological function or pathway)
04

Disease associations

Other (eye disorders, specifically retinal/macular conditions)
05

Safety considerations

Surgical risks (e.g., infection, bleeding, retinal detachment) are the main concerns associated with treatment
06

Interacting drugs

None (no pharmacological or molecular drugs target the membrane directly; treatment is surgical)
07

Biomarkers

None known for direct patient selection or response monitoring; diagnosis is based on clinical ophthalmic imaging (OCT, fluorescein angiography, ophthalmoscopy)

Beyond the preview

Go deeper on Epiretinal membrane (ERM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epiretinal membrane (ERM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call